number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide and key differences, results (2026) GLP-1 Medications for Weight Loss:

Winner: TIE Availability Both semaglutide and tirzepatide are highly sought after medications

What we do know from the switching protocols published by various clinical practices is that starting low and titrating up works better than trying to jump to an "equivalent" dose

If you are using compounded medication and managing your own escalation, stick to the minimum four-week intervals

discontinue if suspected

"Efficacy and Safety of Retatrutide in Adults with Obesity." NEJM

Januvia (Sitagliptin) Sales in 2022: $4.513 billion (includes sales of Janumet (sitagliptin + metformin)) Company/Developer: Merck Date of first FDA approval: October 16, 2006 Indications Januvia is FDA-approved for: Type 2 diabetes Price of Januvia: About $613 for a supply of 30 oral 100 mg tablets Why it did so well: Januvia is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated to improve glycemic control in patients with type 2 diabetes in conjunction with diet and exercise